Heregulin expression and its clinical implication for patients with EGFR-mutant non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitors

Journal Article published Dec 2019 in Scientific Reports volume 9 issue 1

Research funded by Chugai Pharmaceutical | AbbVie | MSD K.K. | Takeda Pharmaceutical Company | Pfizer Japan | Bristol-Myers Squibb | AstraZeneca | Boehringer Ingelheim | Novartis Pharmaceuticals Corporation | Daiichi Sankyo Company | Astellas Pharma | Taiho Pharmaceutical | Eli Lilly and Company | Merck & Co., Inc. | MSD K.K. | Merck & Co., Inc. | MSD K.K. | Merck & Co., Inc. | MSD K.K. | Merck & Co., Inc. | MSD K.K.

Authors: Kimio Yonesaka, Eiji Iwama, Hidetoshi Hayashi, Shinichiro Suzuki, Ryoji Kato, Satomi Watanabe, Takayuki Takahama, Junko Tanizaki, Kaoru Tanaka, Masayuki Takeda, Kazuko Sakai, Koichi Azuma, Yasutaka Chiba, Shinji Atagi, Kazuto Nishio, Isamu Okamoto, Kazuhiko Nakagawa

Subjective social status via mediation of childhood parenting is associated with adulthood depression in non-clinical adult volunteers

Journal Article published Apr 2019 in Psychiatry Research volume 274 on pages 352 to 357

Research funded by Chugai Pharmaceutical | AbbVie | Research and Development | Daiichi-Sankyo | Pfizer | Dainippon Sumitomo Pharma | Otsuka Pharmaceutical | Japan Agency for Medical Research and Development | Japan Agency for Medical Research and Development | Takeda Pharmaceutical Company | GlaxoSmithKline | Eisai | Meiji Seika Pharma | Times Higher Education | Asahi Kasei Pharma Corporation | Boehringer Ingelheim | Kyowa Hakko Kirin | Ministry of Education | SENSHIN Medical Research Foundation | Ono Pharmaceutical | Novartis Pharma | Eli Lilly and Company | Astellas | MSD | Tanabe Mitsubishi Pharma | Shionogi and Yoshitomiyakuhin | Japanese | Japan Agency for Medical

Authors: Taito Hayashida, Motoki Higashiyama, Keisuke Sakuta, Jiro Masuya, Masahiko Ichiki, Ichiro Kusumi, Takeshi Inoue

Significance of liver stiffness measurement by acoustic radiation force impulse (ARFI) among hepatitis C patients

Journal Article published Feb 2014 in Journal of Medical Virology volume 86 issue 2 on pages 241 to 247

Research funded by Merck Sharp and Dohme | Chugai Pharmaceutical

Authors: Ryoko Yamada, Naoki Hiramatsu, Tsugiko Oze, Naoki Morishita, Naoki Harada, Masanori Miyazaki, Takayuki Yakushijin, Takuya Miyagi, Yuichi Yoshida, Tomohide Tatsumi, Tatsuya Kanto, Norio Hayashi, Tetsuo Takehara

P-200 A phase II study of dose reductive XELOX plus bevacizumab in elderly or vulnerable patients with metastatic colorectal cancer: MCSGO-1202

Journal Article published Jul 2021 in Annals of Oncology volume 32 on page S168

Research funded by Astellas Pharma | Ono Pharmaceutical | Eli Lilly and Company | Chugai Pharmaceutical

Authors: K. Nakata, D. Sakai, J. Hasegawa, T. Kato, K. Murata, M. Ikenaga, T. Kudo, M. Uemura, T. Satoh, T. Mizushima, Y. Doki, H. Eguchi

P-37 SGNTUC-019: Phase 2 basket study of tucatinib and trastuzumab in previously treated solid tumors with HER2 alterations: Biliary tract cancer cohort (trial in progress)

Journal Article published Jul 2021 in Annals of Oncology volume 32 on pages S108 to S109

Research funded by Chugai Pharmaceutical

Authors: T. Bekaii-Saab, V. Kang, L. Walker, Y. Nakamura

P-97 Updated results of HGCSG1603: A phase 2 trial of ramucirumab plus irinotecan combination therapy as second-line treatment for patients with advanced gastric cancer

Journal Article published Jul 2021 in Annals of Oncology volume 32 on page S131

Research funded by Eli Lilly Japan | Taiho Pharmaceutical | Chugai Pharmaceutical

Authors: M. Nakamura, Y. Kawamoto, S. Yuki, K. Sawada, O. Muto, S. Sogabe, Y. Shindo, A. Ishiguro, A. Sato, Y. Tsuji, M. Dazai, H. Okuda, T. Sasaki, K. Harada, H. Nakatsumi, K. Iuchi, Y. Sakata, Y. Komatsu

P-81 HGCSG1901: A retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer: Analysis of second-line treatment

Journal Article published Jul 2021 in Annals of Oncology volume 32 on page S125

Research funded by Taiho Pharmaceutical | Chugai Pharmaceutical

Authors: S. Kaneko, K. Ito, S. Yuki, K. Harada, M. Yagisawa, K. Sawada, A. Ishiguro, O. Muto, K. Hatanaka, H. Okuda, A. Sato, Y. Sasaki, M. Nakamura, T. Sasaki, Y. Tsuji, T. Ando, K. Kato, T. Wakabayashi, M. Kotaka, Y. Takahashi, Y. Sakata, Y. Komatsu

Reply

Journal Article published Jul 2021 in Gastroenterology volume 161 issue 1 on pages 367 to 368

Research funded by Uehara Memorial Foundation | Chugai Pharmaceutical | Takeda Science Foundation | Boehringer Ingelheim

Authors: Takeshi Iwaya, Satoshi S. Nishizuka

Bevacizumab improves overall survival in platinum refractory ovarian cancer patients: A retrospective study

Journal Article published Dec 2018 in Taiwanese Journal of Obstetrics and Gynecology volume 57 issue 6 on pages 819 to 824

Research funded by Chugai Pharmaceutical | Yakult Pharmaceutical Industry Co | Japan Vaccine Co | MSD Japan

Authors: Kenro Chikazawa, Sachiho Netsu, Tomoyuki Kuwata, Ryo Konno

Questionnaire survey on adjuvant chemotherapy for elderly patients after gastrectomy indicates their vulnelabilities

Journal Article published Jan 2019 in Gastric Cancer volume 22 issue 1 on pages 130 to 137

Research funded by Chugai Pharmaceutical | Daiichi-Sankyo | Dainippon Sumitomo Pharma | Otsuka Pharmaceutical | Takeda Pharmaceutical Company | Johnson and Johnson | Olympus | Covidien | Novartis Pharma | Sanofi | Taiho Pharmaceutical | Ono Pharmaceutical | Yakult Honsha | Eli Lilly Japan | Merck Serono | EA Pharma | Nippon Kayaku | MSD | Bayer Yakuhin | Ministry of Health, Labor and Welfare | Ono Parmaceutical | Kaken Pharmaceutical

Authors: Toshiyuki Tanahashi, Kazuhiro Yoshida, Kazuya Yamaguchi, Naoki Okumura, Atsushi Takeno, Kazumasa Fujitani, Norimasa Fukushima, Nobuhiro Takiguchi, Yasunori Nishida, Narikazu Boku, Takaki Yoshikawa, Masanori Terashima